| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/15/2013 | US20130210076 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130209583 Methods and compositions suitable for promoting healthy skin |
| 08/15/2013 | US20130209578 Combinatory Cancer Treatment |
| 08/15/2013 | US20130209563 Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 08/15/2013 | US20130209561 Abuse-resistant opioid dosage form |
| 08/15/2013 | US20130209558 Oral Dosage Forms of Bendamustine and Therapeutic Use Thereof |
| 08/15/2013 | US20130209551 Pentapeptide derivatives for promoting hair growth |
| 08/15/2013 | US20130209550 Anti-Viral Azide Containing Compounds |
| 08/15/2013 | US20130209549 Materials and methods for treating neurodegenerative diseases |
| 08/15/2013 | US20130209546 Combinatorial methods and compositions for treatment of melanoma |
| 08/15/2013 | US20130209531 Applications of partially and fully sulfated hyaluronan |
| 08/15/2013 | US20130209525 Controlled release formulations of opioid and nonopioid analgesics |
| 08/15/2013 | US20130209516 Immunomodulatory compositions |
| 08/15/2013 | US20130209505 Crystalline form of (2s,4r)-5-biphenyl-4-yl-2-hydroxymethyl-2-methyl-4-[(1h-[1,2,3]triazole-4-carbonyl)-amino]-pentanoic acid 5-methyl-2-oxo-[1,3]dioxol-4-ylmethyl ester |
| 08/15/2013 | US20130209502 Alumina nanoparticle bioconjugates and methods of stimulating an immune response using said bioconjugates |
| 08/15/2013 | US20130209490 Diagnostic BioMarkers for Fibrotic Disorders |
| 08/15/2013 | US20130209488 Methods and compositions for malic enzyme 2 (me2) as a target for cancer therapy |
| 08/15/2013 | US20130209483 Cannabidinoid derivatives |
| 08/15/2013 | US20130209480 Methods of treating rheumatoid arthritis using il-17 antagonists |
| 08/15/2013 | US20130209477 Agents and method for treating inflammation-related conditions and diseases |
| 08/15/2013 | US20130209473 R-spondin translocations and methods using the same |
| 08/15/2013 | US20130209459 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/15/2013 | US20130209451 Treatments for Cancer |
| 08/15/2013 | US20130209447 Methods and kits for predicting the risk of diabetes associated complications using genetic markers and arrays |
| 08/15/2013 | US20130209446 Copy Number Variant-Dependent Genes As Diagnostic Tools, Predictive Biomarkers And Therapeutic Targets |
| 08/15/2013 | US20130209444 Non-anticoagulant sulfated or sulfonated polysaccharides |
| 08/15/2013 | US20130209438 Prostatic Acid Phosphatase for the Treatment of Pain |
| 08/15/2013 | US20130209433 Modulation of amino acid metabolism in the hypothalamus |
| 08/15/2013 | US20130209424 Compositions for promoting hematopoietic stem cell growth |
| 08/15/2013 | US20130209408 Bacteriophage-containing therapeutic agents |
| 08/15/2013 | US20130209404 Treatment of IBD and IBS Using Both Probiotic Bacteria and Fermented Cereal as Treatment Effectors |
| 08/15/2013 | US20130209403 Use of inhibitors of phospholipase a2 for the treatment or prevention of flavivirus infection |
| 08/15/2013 | US20130209401 Compositions and methods for inhibiting entry of a hepatic virus |
| 08/15/2013 | US20130209400 Pyrazole derivatives as jak inhibitors |
| 08/15/2013 | US20130209399 Anti-virus therapy for respiratory diseases |
| 08/15/2013 | US20130209398 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130209397 Heterocyclic antiviral compounds |
| 08/15/2013 | US20130209394 Mn/ca ix and egfr pathway inhibition |
| 08/15/2013 | US20130209366 Glutathione-Lanthionine Compounds and Methods Related Thereto |
| 08/15/2013 | US20130209355 Antibodies against human cd38 |
| 08/14/2013 | EP2626414A1 Cancer stem cell mass and process for production thereof |
| 08/14/2013 | EP2626075A1 Use of inhaled xenon for preventing or treating neuropathic pain induced by a cancer chemotherapy substance |
| 08/14/2013 | EP2626067A1 Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy |
| 08/14/2013 | EP2626066A1 Combination therapy comprising selective VEGFR-2 inhibitors and MEK inhibitors |
| 08/14/2013 | EP2626065A1 Compound composition for inhalation used for treating asthma |
| 08/14/2013 | EP2624866A2 Tumor specific antibodies and uses therefor |
| 08/14/2013 | EP2624847A2 Human lung stem cells and uses thereof |
| 08/14/2013 | EP2624840A1 New treatments of hepatitis c virus infection |
| 08/14/2013 | EP2624826A1 Vitamin e formulations of sulfamide ns3 inhibitors |
| 08/14/2013 | CN103243161A Product for performing assisted prediction on postoperative survival time length of esophageal squamous carcinoma patient |
| 08/14/2013 | CN103239725A Compound preparation for treating cardiovascular and cerebrovascular diseases |
| 08/14/2013 | CN103239724A Anti-thrombosis combined drug and pharmaceutical composition thereof |
| 08/14/2013 | CN103239723A Compound antihypertensive agent |
| 08/14/2013 | CN103239722A Regulating effect of 5-HT2C receptor-specific agonist on basic rhythmical respiration discharge of mammal medulla oblongata |
| 08/14/2013 | CN103239721A External preparation composition comprising fatty acid-based ionic liquid as active ingredient |
| 08/14/2013 | CN103239720A Substance for curing or relieving pain |
| 08/14/2013 | CN103239719A Metformin compound pharmaceutical composition and preparation method thereof |
| 08/14/2013 | CN103239716A Application of SIRT1 (silent information regulator 1) in preparation of medicines for treating severe burns or wounds |
| 08/14/2013 | CN102389512B Application of extracts of Chinese herbal medicine aloe in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 08/14/2013 | CN102389458B Application of Chinese herbal medicine Radix Salviae Miltiorrhizae extract for preparing anti-obesity and antihyperlipidemic drugs or drugs with lipase activity inhibitory effect |
| 08/14/2013 | CN102389444B Application of extracts of Chinese herbal medicine jasmine in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 08/14/2013 | CN102370681B Application of extracts of Chinese herbal medicine rhizoma ligustici wallichii in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 08/14/2013 | CN102370676B Application of extracts of Chinese herbal medicine fructus chebulae in preparation of weight-losing and lipid-lowering medicines or medicines with function of inhibiting lipase activity |
| 08/14/2013 | CN101909604B Method of treating dysglycemia and glucose excursions |
| 08/14/2013 | CN101791406B Use of sphingosine-1-phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases |
| 08/14/2013 | CN101700401B Polyalkylene glycol with moiety for conjugating biologicallyactive compound |
| 08/14/2013 | CN101664551B Stabilization of hypoxia inducible factor (HIF) alpha |
| 08/13/2013 | US8507722 Hepatitis C virus inhibitors |
| 08/13/2013 | US8507710 Use of perifosine in combination with antimetabolites for the treatment of benign and malignant oncoses in humans and mammals |
| 08/13/2013 | US8507430 Methods for administering FGF18 |
| 08/13/2013 | US8507276 Tissue culture media used as a component of cosmetics |
| 08/13/2013 | US8507009 Colonic purgative composition with soluble binding agent |
| 08/13/2013 | US8506971 Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria |
| 08/13/2013 | US8506966 Adjuvanted influenza vaccines for pediatric use |
| 08/13/2013 | US8506958 Methods for treating TWEAK-related conditions |
| 08/13/2013 | CA2768841C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768828C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2768773C Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 08/13/2013 | CA2650478C Compositions comprising a dissociated glucocorticoid receptor agonist and an immunosuppressive agent for treating dry eye |
| 08/13/2013 | CA2621059C Stabilized protease composition |
| 08/13/2013 | CA2571462C Composition for preventing recurrence of stroke |
| 08/13/2013 | CA2569888C Use of l-carnitine for the treatment of cardiovascular diseases |
| 08/13/2013 | CA2488803C Use of ramoplanin to treat diseases associated with the use of antibiotics |
| 08/13/2013 | CA2464121C Pregnancy-associated plasma protein-a2 (papp-a2) |
| 08/13/2013 | CA2438513C Modified anti-egfr antibodies with reduced immunogenicity |
| 08/13/2013 | CA2393141C Novel methods for the treatment and prevention of ileus |
| 08/08/2013 | WO2013116590A1 Inhibition of pattern recognition receptors in pancreatic cancer treatment using tlr inhibitors |
| 08/08/2013 | WO2013116293A1 Combination of a rtk inhibitor with an anti - estrogen and use thereof for the treatment of cancer |
| 08/08/2013 | WO2013116126A1 Novel low molecular weight, biodegradable cationic lipids for oligonucleotide delivery |
| 08/08/2013 | WO2013115746A1 A production method for (effervescent) pharmaceutical compositions comprising an alpha - glucosidase inhibitor (miglitol) and metformin |
| 08/08/2013 | WO2013115745A1 A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
| 08/08/2013 | WO2013115744A1 A process for production of pharmaceutical (effervescent) composition comprising alpha - glucosidase inhibitor (e.g. vogliobose and metformin) |
| 08/08/2013 | WO2013115743A1 Effervescent tablet formulations comprising the combination of voglibose and metformin |
| 08/08/2013 | WO2013115742A1 Pharmaceutical composition comprising alpha-glucosidase inhibitor |
| 08/08/2013 | WO2013115741A1 Pharmaceutical compositions comprising alpha-glucosidase inhibitor |
| 08/08/2013 | WO2013115738A1 Micronized acarbose |
| 08/08/2013 | WO2013113799A1 Phenyl -c-oxadiazole derivatives as inhibitors of leukotriene production combination therapy |
| 08/08/2013 | WO2013113496A1 Hydroxyalkyl starch in combination with cytostatica for the treatment of cancers by reduction of tumor growth rates |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130203975 Glycoside derivatives and uses thereof |